2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine

2,4-dichloro-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidine

Pharmaceutical intermediate for kinase inhibitors

Tert-Butyl 4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate

Pharmaceutical intermediate for kinase inhibitors

1-(benzenesulfonyl)-4-chloro-5-nitro-1H-pyrrolo[2,3-b]pyridine

Pharmaceutical intermediate for kinase inhibitors

Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate

Pharmaceutical intermediate for kinase inhibitors

1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate

Pharmaceutical intermediate for upadacitinib synthesis

(1R)-1-(3-chlorophenyl)ethan-1-ol

pharmaceutical intermediate

Ixazomib Impurity 1

Pharmaceutical intermediate for proteasome inhibitor

N,N',N''-((((1R,1'R,1''R)-(1,3,5,2,4,6-trioxatriborinane-2,4,6-triyl)tris(3-methylbutane-1,1-diyl))tris(azanediyl))tris(2-oxoethane-2,1-diyl))tris(2,5-dichlorobenzamide)

Pharmaceutical intermediate